
Ranbaxy receives tentative drug approval from USFDA
The US Food and Drug Administration (USFDA) has granted a tentative approval to Ranbaxy Laboratories Ltd for the manufacturing and marketing of its drug Nexium, popularly prescribed in the treatment of heartburn.
Announcing this here to the Bombay Stock Exchange (BSE) on Thursday, an official statement issued by Ranbaxy Laboratories said that the USFDA has granted approval on Nexium with Esomeprazole 20 mg (base) and 40 mg (base). Nexium is the registered trademark of Astra Zeneca.
According to the pharmaceutical marketing research major Intercontinental Market Services (IMS), in December 2007 Esomeprazole became the second largest selling drug in the US with total annual market sales touching $5.5 billion.
According to the statement, Ranbaxy believes that it has a FTF (First to File) status on the drug, providing it with a potential 180 days marketing exclusivity.
Esomeprazole is indicated for short-term treatment of erosive esophagitis and for treatment of heartburn and other symptoms associated with Gastroesophageal Reflux Disease (GERD.)
The manufacturing and marketing would be done by Jacksonville (Florida) based Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary engaged in the sale and distribution of generic and branded prescription products in the US healthcare system.

Muthoot Group chairman MG George passes away: All you need to know

A weak week for gold: Here's how the bullion fared

Centre, states need to discuss fuel taxes, says Sitharaman
- In an interaction with members of the Indian Women’s Press Corps (IWPC), Sitharaman said that consumer sentiment about the tax burden on auto fuel was understandable.

Reliance to bear the cost of covid shots for its staff
- Nearly 1.1 million vaccine doses were administered to people above the age of 60 and those in the 45-59 age group till Thursday.

Govt plans to scrap 6,000 compliances
- Mohapatra said the idea came during Modi’s meeting with Marriott International president and chief executive Arne Sorenson, who complained about the complex regulations in starting and running a hotel in India.

ICICI cuts home loan rates to a decadal low
- ICICI Bank’s move comes days after rival lenders such as State Bank of India (SBI), Kotak Mahindra Bank and Housing Development Finance Corp. Ltd cut their home loan rates.

Voting on corp resolutions compulsory for MFs: Sebi
- These votes will have to be disclosed to unit holders under existing regulations. Voting will be at the MF level (rather than scheme level).

Toyota SUV sales may skid on gaps in chipset supply
- Supply of vehicles from Maruti Suzuki India Ltd—as part of the alliance with Suzuki Motor Corp—has helped Toyota increase its domestic market share in the premium hatchback and entry-level SUV segment, where it was not present before.

Total factories in India grew by 2% in 2018-19
- The top three states by GVA were Maharashtra, Gujarat, and Tamil Nadu. They had a share of 41% in the total GVA. Rural India added nearly as much GVA (49%) as urban India (51%).

How do India’s fuel taxes impact the less affluent?
- Using average consumption shares to calculate the burden of an indirect tax has a problem.

India says OPEC+ decision to extend oil output cuts will hit economic recovery

Gender inequality has cost world USD 70 trillion since 1990, finds report

Gold price falls further to ₹44,344, sets retail buyers on buying spree
- Retail buyers continued to purchase gold in India as prices declined to a near one-year low.

Sebi lays guidelines on votes cast by mutual funds
